DTaP-poliovirus vaccine (North American Vaccine)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDTaP-poliovirus vaccine (North American Vaccine)

Drug Alias NameNorth American Vaccine (NAV) combination vaccine (DTaP + IPV)DTaP-IPV vaccineDI-TE-KI-POLDTaP-IPVCertiva-IPV +[6]

ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPoliomyelitisTetanusDiphtheria +[4]

Global Approved IndicationsPoliomyelitisTetanusDiphtheria +[4]

Approved Indications in ChinaN/A

Original Approved Country/TerritoryDenmark

Original Approved Date1997/05/12

Country/TerritoryDenmark

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesStatens Serum Institut Baxter International Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesN/A

Active IndicationsPoliomyelitisTetanusDiphtheria +[4]

Inactive IndicationsN/A

Other Information

ATC CodeJ07CA02